ghk-cu microneedling protocol GHK-CU VIBRANCY™ MICRONEEDLING KIT The Anti-Aging Power of GHK-Cu

(2019) musculoskeletal healing WADA Status: Research compound (verify current prohibited list) BIONIX BPC-157 is supplied exclusively for laboratory research purposesnot for therapeutic use, human administration, veterinary, or clinical applications

Bottom line: even if the FDA eventually recommends that certain peptides can be compounded under Section 503A, many stakeholders could still be blocked by the requirement to source pharmaceutical-grade API from an FDA-registered establishment with a Certificate of Analysis and by FDAs demonstrated willingness to police marketing claims around compounded drugs

Oral reduced glutathione: 250-1,000 mg/day based on the Richie et al

Therapeutic Research Protocol Dose: 10 20 mg (= 3061 clicks) Duration: 4 6 weeks Frequency: Daily Cycle Interval: 4-week interval Goal / Description: Modeled on extended NNMT inhibition protocols in DIO models

Copper Peptide GHK-Cu